The ADDF accelerates the discovery of drugs to prevent and treat Alzheimer's disease through research funding and portfolio management.
The Alzheimer's Drug Discovery Foundation (ADDF) is dedicated to advancing the discovery of drugs to prevent and treat Alzheimer's disease. ADDF funds research programs focused on drug development, biomarkers, and prevention strategies. In 2024, ADDF catalyzed significant breakthroughs, including major investments in scalable blood tests and the cataloging of Alzheimer's biomarkers. The foundation also marked the 10th anniversary of the Goodes Prize and celebrated the FDA approval of Kisunla (Donanemab). ADDF's diverse portfolio is one of the largest worldwide, emphasizing lifestyle interventions and innovative diagnostics.
The Department of Psychological & Brain Sciences at Boston University is a globally recognized leader in research. It offers expertise in a broad range of fields and is ranked highly for its combined psychiatry/psychology faculty research strength.
The Department of Psychology at the University of Michigan's LSA (Literature, Science, and the Arts) college offers a comprehensive program for undergraduate students. The department provides academic advising, both in person and online, to help students navigate their studies. It is a hub for foundational knowledge and creative thinking, engaging with a complex, diverse, and changing world.
UCL's Department of Psychology and Language Sciences is dedicated to advancing understanding of human behavior, cognition, and language through innovative research and teaching.